These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1460355)

  • 1. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
    Heidrich H; Witt D; Witt E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1750-2. PubMed ID: 347800
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of controlled vascular training on the pain free walking distance and plasmaviscosity in patients suffering from peripheral arterial occlusive disease.
    Häfner HM; Jünger I; Geyer A; Jünger M; Strölin A
    Clin Hemorheol Microcirc; 2009; 41(1):73-80. PubMed ID: 19136745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
    Streminski JA; de la Haye R; Rettig K; Kuntz G
    Vasa; 1992; 21(4):392-402. PubMed ID: 1485475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
    Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H
    Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G; Trübestein R; Ludwig M
    Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training].
    Scheffler P; de la Hamette D; Müller H
    Vasa Suppl; 1991; 33():350-2. PubMed ID: 1788754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H
    Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
    Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M; Albiani B; Ricci M; Russo F
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Walking training as basic therapy of stage II peripheral arterial occlusive disease--success despite advanced age and concomitant diseases].
    Bunse C; Klemp U; Bisler H
    Vasa Suppl; 1991; 33():176-7. PubMed ID: 1788665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methods and results of controlled walking training in patients with peripheral arterial occlusive disease].
    Cachovan M
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):626-32. PubMed ID: 10666825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.